The only information available is a PR Newswire article reporting that Sha'ar Mivnim took part in Modulight Biotherapeutics’ $12 million seed round. Apart from being named as one of the investors in that financing, no additional corporate or contact details are supplied.
Focus Areas
Notable Investments
